18. SHARE CAPITAL (Details) - CAD ($)
|
12 Months Ended |
Dec. 31, 2020 |
Dec. 31, 2019 |
| Issuance of share capital, net |
[1] |
$ 22,241,753
|
$ 26,299,820
|
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used |
|
Monte Carlo simulation valuation model
|
|
| Shares issued debt settlement, Value |
[1] |
$ 5,848,000
|
|
| Share-based compensation |
[1] |
$ 3,955,976
|
$ 3,796,095
|
| Fair value of the common share purchase warrants |
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used |
|
Monte Carlo valuation model
|
|
| Fair value of the compensation warrants |
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used |
|
both Black-Scholes and Monte Carlo valuation models
|
|
| Options granted during the year |
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used |
|
Black-Scholes option pricing model
|
|
| Warants - 2 |
|
|
|
| Number Outstanding |
|
|
2,001,000
|
| Exercise Price |
|
$ 0.75
|
|
| Options granted #1 |
|
|
|
| Options Grant Date |
|
Jan. 11, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
171,429
|
|
| Exercise Price |
|
$ 1.00
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Jan. 11, 2025
|
|
| Options granted #2 |
|
|
|
| Options Grant Date |
|
Jan. 11, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
200,000
|
|
| Exercise Price |
|
$ 1.00
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Jan. 11, 2025
|
|
| Options granted #3 |
|
|
|
| Options Grant Date |
|
Apr. 01, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
161,250
|
|
| Exercise Price |
|
$ 1.00
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Apr. 01, 2025
|
|
| Options granted #4 |
|
|
|
| Options Grant Date |
|
Jul. 06, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
50,000
|
|
| Exercise Price |
|
$ 0.90
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Jul. 06, 2025
|
|
| Options granted #5 |
|
|
|
| Options Grant Date |
|
Jul. 27, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
50,000
|
|
| Exercise Price |
|
$ 1.00
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Jul. 27, 2025
|
|
| Options granted #6 |
|
|
|
| Options Grant Date |
|
Aug. 11, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
100,000
|
|
| Exercise Price |
|
$ 0.60
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Aug. 11, 2025
|
|
| Options granted #7 |
|
|
|
| Options Grant Date |
|
Sep. 08, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
250,000
|
|
| Exercise Price |
|
$ 0.66
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Sep. 08, 2025
|
|
| Options granted #8 |
|
|
|
| Options Grant Date |
|
Sep. 10, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
15,000
|
|
| Exercise Price |
|
$ 0.66
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Sep. 10, 2025
|
|
| Options granted #9 |
|
|
|
| Options Grant Date |
|
Oct. 01, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
3,400,000
|
|
| Exercise Price |
|
$ 0.65
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Oct. 01, 2025
|
|
| Options granted #10 |
|
|
|
| Options Grant Date |
|
Oct. 01, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
800,000
|
|
| Exercise Price |
|
$ 0.65
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Oct. 01, 2025
|
|
| Options granted #11 |
|
|
|
| Options Grant Date |
|
Oct. 12, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
50,000
|
|
| Exercise Price |
|
$ 0.65
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Oct. 01, 2025
|
|
| Options granted #12 |
|
|
|
| Options Grant Date |
|
Nov. 18, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
350,000
|
|
| Exercise Price |
|
$ 0.67
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Nov. 14, 2025
|
|
| Options granted #13 |
|
|
|
| Options Grant Date |
|
Nov. 18, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
185,000
|
|
| Exercise Price |
|
$ 0.67
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Nov. 18, 2025
|
|
| Options granted #14 |
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
75,000
|
|
| Exercise Price |
|
$ 0.60
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Nov. 06, 2025
|
|
| Options granted #15 |
|
|
|
| Options Grant Date |
|
Dec. 03, 2020
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
|
800,000
|
|
| Exercise Price |
|
$ 0.75
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date |
|
Dec. 03, 2025
|
|
| Common Stock |
|
|
|
| Shares issued for bought deal, Shares |
[1] |
33,350,000
|
|
| Shares issued debt settlement, Value |
[1] |
$ 2,292,416
|
|
| Stock Issued During Period, Shares, Acquisitions |
[2] |
17,133,600
|
|
| Deemed shares issued, Shares |
[3] |
23,464,462
|
|
| Stock Issued During Period, Shares, Issued for Services |
[3] |
7,381,000
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
[1] |
0
|
0
|
| Convertible Series II Preferred |
|
|
|
| Shares issued for bought deal, Shares |
[1] |
|
|
| Shares issued debt settlement, Value |
[1] |
$ 3,555,584
|
|
| Stock Issued During Period, Shares, Acquisitions |
[2] |
17,133,600
|
|
| Deemed shares issued, Shares |
[3] |
0
|
|
| Stock Issued During Period, Shares, Issued for Services |
[3] |
7,381,000
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures |
[1] |
0
|
0
|
| Private Placement #1 |
|
|
|
| Sale of Stock, Transaction Date |
|
Sep. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company closed the bought deal offering for a total issuance of 33,350,000 units of the Company at a price of $0.75 per unit for aggregate gross proceeds of $25,012,500
|
|
| Private Placement #2 |
|
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 1,411,333 units to settle a debt of $1,058,500, of which 866,666 units were issued to the CEO of the Company
|
|
| Debt Settlement #1 |
|
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 2,339,200 units consisting of one common share and one series II preferred shares to a third-party to pay for $5,848,000 owed by PharmaCo to its related party
|
|
| Common Shares #1 |
|
|
|
| Sale of Stock, Transaction Date |
[4] |
Jan. 10, 2020
|
|
| Sale of Stock, Description of Transaction |
[4] |
Company issued rights to receive 17,133,600 common shares of MichiCann to sellers of MAG
|
|
| Common Shares #2 |
|
|
|
| Sale of Stock, Transaction Date |
|
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
[3] |
Company issued 23,464,462 common shares to holders of Tidal common shares
|
|
| Common Shares #3 |
|
|
|
| Sale of Stock, Transaction Date |
[3] |
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
[3] |
Company issued 7,381,000 common shares to related parties
|
|
| Common Shares #4 |
|
|
|
| Sale of Stock, Transaction Date |
|
Apr. 30, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 429,375 common shares pursuant to the exercise of 429,375 warrants for gross proceeds of $343,500
|
|
| Common Shares #5 |
|
|
|
| Sale of Stock, Transaction Date |
|
May 25, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 187,500 common shares pursuant to the exercise of 187,500 warrants for gross proceeds of $150,000
|
|
| Common Shares #6 |
|
|
|
| Sale of Stock, Transaction Date |
|
Jun. 08, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 975,000 of common shares and 975,000 convertible series II preferred shares pursuant to the exercise of 975,000 stock options for gross proceeds of $487,500
|
|
| Common Shares #7 |
|
|
|
| Sale of Stock, Transaction Date |
[2] |
Jun. 10, 2020
|
|
| Sale of Stock, Description of Transaction |
[2] |
Company issued 13,500,000 common shares pursuant to High Times Licensing Agreement
|
|
| Common Shares #8 |
|
|
|
| Sale of Stock, Transaction Date |
[2] |
Jun. 10, 2020
|
|
| Sale of Stock, Description of Transaction |
[2] |
Company issued 1,800,000 common shares to finde
|
|
| Common Shares #9 |
|
|
|
| Sale of Stock, Transaction Date |
[5] |
Jun. 30, 2020
|
|
| Sale of Stock, Description of Transaction |
[5] |
Company issued 2,339,200 units consisting of one common share and one series II preferred share
|
|
| Common Shares #10 |
|
|
|
| Sale of Stock, Transaction Date |
|
Aug. 13, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 500,000 common shares and 500,000 convertible series II preferred shares
|
|
| Common Shares #11 |
|
|
|
| Sale of Stock, Transaction Date |
|
Sep. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 500,000 common shares pursuant to transaction cost for $10,000,000 convertible debenture
|
|
| Common Shares #12 |
|
|
|
| Sale of Stock, Transaction Date |
|
Nov. 25, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 6,000 common shares and 6,000 convertible series II preferred shares
|
|
| Common Shares #13 |
|
|
|
| Sale of Stock, Transaction Date |
|
Dec. 02, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 47,910 common shares and 47,910 convertible series II preferred shares
|
|
| Common Shares #14 |
|
|
|
| Sale of Stock, Transaction Date |
|
Dec. 03, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 175,000 common shares and 175,000 convertible series II preferred shares
|
|
| Common Shares #15 |
|
|
|
| Sale of Stock, Transaction Date |
|
Dec. 08, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 400,000 common shares and 400,000 convertible series II preferred shares
|
|
| Common Shares #16 |
|
|
|
| Sale of Stock, Transaction Date |
|
Dec. 15, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 4,500,000 common shares pursuant to the exercise of warrants
|
|
| Common Shares #17 |
|
|
|
| Sale of Stock, Transaction Date |
|
Dec. 17, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 416,430 common shares and 416,430 convertible series II preferred shares pursuant to the exercise of warrants for gross proceeds of $416,430
|
|
| Convertible Series I Preferred Shares #1 |
|
|
|
| Sale of Stock, Transaction Date |
[3] |
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
[3] |
Company issued 3,181,250 convertible series I preferred shares to Tidal shareholders
|
|
| Convertible Series II Preferred Shares #1 |
|
|
|
| Sale of Stock, Transaction Date |
[3] |
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
[3] |
Company issued 101,345,349 to holders of MichiCann convertible series II preferred shares pursuant to Amended Agreement of the reverse takeover transaction
|
|
| Convertible Series II Preferred Shares #2 |
|
|
|
| Sale of Stock, Transaction Date |
[2] |
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
[2] |
Company issued 17,133,600 to sellers of MAG convertible series II preferred shares pursuant to MAG acquisition
|
|
| Convertible Series II Preferred Shares #3 |
|
|
|
| Sale of Stock, Transaction Date |
[3] |
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
[3] |
Company issued 7,381,000 convertible series II preferred shares to related parties
|
|
| Warrants #1 |
|
|
|
| Sale of Stock, Transaction Date |
|
Dec. 19, 2018
|
|
| Sale of Stock, Description of Transaction |
|
MichiCann issued 595,340 finders' warrants
|
|
| Warrants #2 |
|
|
|
| Sale of Stock, Transaction Date |
|
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 862,813 warrants to holders of Tidal warrants
|
|
| Warrants #3 |
|
|
|
| Sale of Stock, Transaction Date |
|
Apr. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 323,898 warrants towards finder's fee
|
|
| Warrants #4 |
|
|
|
| Sale of Stock, Transaction Date |
|
Jun. 10, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 4,500,000 special warrants related to the 1251881 B.C. Ltd. acquisition
|
|
| Warrants #5 |
|
|
|
| Sale of Stock, Transaction Date |
|
Sep. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 33,350,000 warrants pursuant to bought deal financing agreement
|
|
| Warrants #6 |
|
|
|
| Sale of Stock, Transaction Date |
|
Sep. 24, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company issued 2,001,000 warrants to finders pursuant to bought deal financing agreement
|
|
| Options #1 |
|
|
|
| Sale of Stock, Transaction Date |
|
Jul. 27, 2020
|
|
| Sale of Stock, Description of Transaction |
|
Company adopted a rolling stock option plan
|
|
|
|